These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26255966)

  • 1. Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder.
    Dong LF; Yao J; Wang XQ; Shan K; Yang H; Yan B; Jiang Q
    Biochem Biophys Res Commun; 2015 Oct; 465(4):678-84. PubMed ID: 26255966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA-181a inhibits ocular neovascularization by interfering with vascular endothelial growth factor expression.
    Yang C; Tahiri H; Cai C; Gu M; Gagnon C; Hardy P
    Cardiovasc Ther; 2018 Jun; 36(3):e12329. PubMed ID: 29608244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions.
    Lu L; Payvandi F; Wu L; Zhang LH; Hariri RJ; Man HW; Chen RS; Muller GW; Hughes CC; Stirling DI; Schafer PH; Bartlett JB
    Microvasc Res; 2009 Mar; 77(2):78-86. PubMed ID: 18805433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis.
    Mei X; Zhou L; Zhang T; Lu B; Sheng Y; Ji L
    Vascul Pharmacol; 2018 Feb; 101():29-37. PubMed ID: 29146180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFα induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation.
    Shanmuganathan S; Angayarkanni N
    Vascul Pharmacol; 2018 Sep; 108():23-35. PubMed ID: 29678603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammalian Target of Rapamycin (mTOR) as a Potential Therapeutic Target in Pathological Ocular Angiogenesis.
    Nakahara T; Morita A; Yagasaki R; Mori A; Sakamoto K
    Biol Pharm Bull; 2017; 40(12):2045-2049. PubMed ID: 29199229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
    Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quercetin inhibits vascular endothelial growth factor-induced choroidal and retinal angiogenesis in vitro.
    Li F; Bai Y; Zhao M; Huang L; Li S; Li X; Chen Y
    Ophthalmic Res; 2015; 53(3):109-16. PubMed ID: 25676100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 Activator RS9 Suppresses Pathological Ocular Angiogenesis and Hyperpermeability.
    Nakamura S; Noguchi T; Inoue Y; Sakurai S; Nishinaka A; Hida Y; Masuda T; Nakagami Y; Horai N; Tsusaki H; Hara H; Shimazawa M
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1943-1952. PubMed ID: 31050722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agents that bind annexin A2 suppress ocular neovascularization.
    Lima e Silva R; Shen J; Gong YY; Seidel CP; Hackett SF; Kesavan K; Jacoby DB; Campochiaro PA
    J Cell Physiol; 2010 Nov; 225(3):855-64. PubMed ID: 20607799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-binding aptides and the inhibition of choroidal and retinal neovascularization.
    Jo DH; Kim S; Kim D; Kim JH; Jon S; Kim JH
    Biomaterials; 2014 Mar; 35(9):3052-9. PubMed ID: 24388818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lonicerae Japonicae Flos attenuates diabetic retinopathy by inhibiting retinal angiogenesis.
    Zhou L; Zhang T; Lu B; Yu Z; Mei X; Abulizi P; Ji L
    J Ethnopharmacol; 2016 Aug; 189():117-25. PubMed ID: 27196298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
    Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
    EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential hypoxic response of human choroidal and retinal endothelial cells proposes tissue heterogeneity of ocular angiogenesis.
    Mammadzada P; Gudmundsson J; Kvanta A; André H
    Acta Ophthalmol; 2016 Dec; 94(8):805-814. PubMed ID: 27255568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial deletion of phospholipase D2 reduces hypoxic response and pathological angiogenesis.
    Ghim J; Moon JS; Lee CS; Lee J; Song P; Lee A; Jang JH; Kim D; Yoon JH; Koh YJ; Chelakkot C; Kang BJ; Kim JM; Kim KL; Yang YR; Kim Y; Kim SH; Hwang D; Suh PG; Koh GY; Kong YY; Ryu SH
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1697-703. PubMed ID: 24947526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic role and therapeutic potential of pleiotrophin in mouse models of ocular vascular disease.
    Wang W; LeBlanc ME; Chen X; Chen P; Ji Y; Brewer M; Tian H; Spring SR; Webster KA; Li W
    Angiogenesis; 2017 Nov; 20(4):479-492. PubMed ID: 28447229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-Derived Vascular Endothelial Growth Factor and Hypoxia-Inducible Factor Are Dispensable for Ocular Neovascularization--Brief Report.
    Liyanage SE; Fantin A; Villacampa P; Lange CA; Denti L; Cristante E; Smith AJ; Ali RR; Luhmann UF; Bainbridge JW; Ruhrberg C
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):19-24. PubMed ID: 26603154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-LGND2, an ERβ selective agonist, inhibits pathologic retinal neovascularization.
    Giddabasappa A; Eswaraka JR; Barrett CM; Bauler MN; Wu Z; Yepuru M; Miller DD; Dalton JT
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):5066-75. PubMed ID: 22714897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy.
    Zhang SX; Ma JX
    Prog Retin Eye Res; 2007 Jan; 26(1):1-37. PubMed ID: 17074526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
    Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
    PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.